United Guardian (UG) Net Cash Flow (QoQ) (2010 - 2026)
Powered by 
Analysis
United Guardian (UG) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.97 Bn | 622.21 Bn | 17.26 Bn |
| 2 | AbbVie | 441.24 Bn | 434.67 Bn | 12.70 Bn |
| 3 | Merck | 364.65 Bn | 357.51 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.30 Bn | 258.61 Bn | 11.24 Bn |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - |
| 8 | Incyte | 25.27 Bn | 20.73 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn |
| 10 | United Guardian | 32.67 Mn | 23.07 Mn | 1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 421.19% |
| Mar 31, 2026 | -232.03% |
| Dec 31, 2025 | 143.00% |
| Sep 30, 2025 | -281.79% |
| Jun 30, 2025 | 182.33% |
| Mar 31, 2025 | -7.10% |
| Dec 31, 2024 | 90.50% |
| Sep 30, 2024 | -547.68% |
| Jun 30, 2024 | 213.87% |
| Mar 31, 2024 | -203.80% |
| Dec 31, 2023 | 77.98% |
| Sep 30, 2023 | -88.01% |
| Jun 30, 2023 | 1,321.52% |
| Mar 31, 2023 | 11.25% |
| Dec 31, 2022 | 136.90% |
| Sep 30, 2022 | -90.87% |
| Jun 30, 2022 | 7,929.68% |
| Mar 31, 2022 | 87.73% |
| Dec 31, 2021 | -205.88% |
| Sep 30, 2021 | -102.52% |